Giulia Taraboletti

Laboratory of Tumor Microenvironment, Head

Istituto di Ricerche Farmacologiche Mario Negri IRCCS

Italy

Research Interests

Explore related searches

Professors in Italy Professors in Tissue Engineering Tissue Engineering professors in Italy

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Giulia Taraboletti is the Head of the Laboratory of Tumor Microenvironment at IRCCS Istituto di Ricerche Farmacologiche Mario Negri in Italy. Her research primarily focuses on tumor biology, particularly the roles of thrombospondins and fibronectin in tumor growth and resistance to therapies. Recent articles by Professor Taraboletti explore the molecular mechanisms of angiogenesis and extracellular interactions that influence drug efficacy in cancer treatment.

Articles (10)

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Collaborators (2)

Alice Passoni

Istituto di Ricerche Farmacologiche Mario Negri IRCCS

ITALY

View details

fabio sangalli

Istituto di Ricerche Farmacologiche Mario Negri IRCCS

ITALY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Giulia Taraboletti

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

Thrombospondin-1 in drug activity and tumor response to therapies

Controlled extracellular proteolysis of thrombospondins

Fibronectin fragments generated by pancreatic trypsin act as endogenous inhibitors of pancreatic tumor growth

Identification of a novel extracellular inhibitor of FGF2/FGFR signaling axis by combined virtual screening and NMR spectroscopy approach

Inhibition of FGFR Signaling by Targeting FGF/FGFR Extracellular Interactions: Towards the Comprehension of the Molecular Mechanism through NMR Approaches

Tumor vascular remodeling by thrombospondin-1 enhances drug delivery and antineoplastic activity

Alternative Vascularization Mechanisms in Tumor Resistance to Therapy

Front Cover: Molecular Basis of the Antiangiogenic Action of Rosmarinic Acid, a Natural Compound Targeting Fibroblast Growth Factor‐2/FGFR Interactions (ChemBioChem 1/2021)

Molecular Basis of the Antiangiogenic Action of Rosmarinic Acid, a Natural Compound Targeting Fibroblast Growth Factor‐2/FGFR Interactions

Thrombospondins in bone remodeling and metastatic bone disease.

Collaborators (2)

Alice Passoni

fabio sangalli

Make your next move.